Access site bleeding after transcatheter aortic valve implantation.
Access site bleeding after transcatheter aortic valve implantation.
复制标题
经导管主动脉瓣植入后通路部位出血。
DOI：
10.1007/s11239-013-0928-6
复制
发表时间：
2013
影响因子：
4
通讯作者：
Frankel,Robert
中科院分区：
文献类型：
--
作者：
Sharma,Abhishek;Arbab-Zadeh,Armin;Dubey,Divyanshu;Shani,Jacob;Lazar,Jason;Frankel,Robert
外科主动脉瓣置换术可改善重度主动脉瓣狭窄患者的发病率和死亡率，是有症状患者的首选治疗方法。由于手术风险高，三分之一的重度AS患者被认为是不可手术的。最近，经导管主动脉瓣植入术（TAVI）已被证明可改善因手术风险高而被认为不可手术的患者的生存率、生活质量和功能状态。然而，穿刺部位和非穿刺部位出血是TAVI后的主要手术并发症，并与较差的临床结局相关。在这篇综述中，我们系统地研究了与TAVI相关的穿刺部位并发症以及可以最大限度地减少这些并发症的方法。
Surgical aortic valve replacement improves morbidity and mortality in patients with severe aortic valve stenosis and is treatment of choice for symptomatic patients. As high, one-third of patients with severe AS are considered inoperable due to associated high surgical risk. Recently, transcatheter aortic valve implantation (TAVI) has been demonstrated to improve survival, quality of life, and functional status in patients who are considered inoperable due to high risk of surgery. However, access site and non-access site bleeding are major procedural complications after TAVI and are associated with worse clinical outcomes. In this review, we systematically study the access site complication associated with TAVI and approaches that can minimize these complications.